NorthView Acquisition Corporation (NVAC)

NASDAQ: NVAC · IEX Real-Time Price · USD
-0.33 (-2.84%)
At close: Apr 17, 2024, 4:00 PM
+0.02 (0.18%)
After-hours: Apr 17, 2024, 4:00 PM EDT
Market Cap 68.17M
Revenue (ttm) n/a
Net Income (ttm) 3.90M
Shares Out 6.03M
EPS (ttm) 0.16
PE Ratio 70.69
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,284
Open 11.34
Previous Close 11.64
Day's Range 11.31 - 12.25
52-Week Range 10.34 - 12.42
Beta 0.02
Analysts n/a
Price Target n/a
Earnings Date n/a

About NVAC

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Dec 21, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol NVAC
Full Company Profile

Financial Performance

Financial Statements


NorthView Acquisition Corp Announces Filing a Registration Statement on Form S-4 in Connection with a Proposed Business Combination with Profusa, Inc.

Reflects continuing advancement in the business combination process; transaction expected to be completed during the second quarter of 2023 Reflects continuing advancement in the business combination ...

1 year ago - GlobeNewsWire

Profusa, Inc., a Digital Health Company, Pioneering the Next Generation of Personalized Medicine, to Become a Publicly Traded Company Via Merger with NorthView Acquisition Corp

New York, New York, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa”), a digital health company that is pioneering the next generation of personalized medicine and NorthView Acquisition Corp...

1 year ago - GlobeNewsWire